417
Participants
Start Date
March 22, 2021
Primary Completion Date
September 7, 2022
Study Completion Date
August 16, 2023
Iloperidone
Oral iloperidone
Iloperidone Placebo
Oral placebo
Vanda Investigational Site, Novi Iskar
Vanda Investigational Site, Vratsa
Vanda Investigational Site, Veliko Tarnovo
Vanda Investigational Site, Tserova Koria
Vanda Investigational Site, Lovech
Vanda Investigational Site, Kardzhali
Vanda Investigational Site, Gaithersburg
Vanda Investigational Site, Decatur
Vanda Investigational Site, Atlanta
Vanda Investigational Site, Miami Lakes
Vanda Investigational Site, Oakland Park
Vanda Investigational Site, Flowood
Vanda Investigational Site, North Canton
Vanda Investigational Site, Dayton
Vanda Investigational Site, Little Rock
Vanda Investigational Site, Rogers
Vanda Investigational Site, Richardson
Vanda Investigational Site, DeSoto
Vanda Investigational Site, Austin
Vanda Investigational Site, Las Vegas
Vanda Investigational Site, Culver City
Vanda Investigational Site, Torrance
Vanda Investigational Site, Cerritos
Vanda Investigational Site, Long Beach
Vanda Investigational Site, Orange
Vanda Investigational Site, Marlton
Vanda Investigational Site, Tuszyn
Lead Sponsor
Vanda Pharmaceuticals
INDUSTRY